These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 12543791

  • 1. The designed angiostatic peptide anginex synergistically improves chemotherapy and antiangiogenesis therapy with angiostatin.
    Dings RP, Yokoyama Y, Ramakrishnan S, Griffioen AW, Mayo KH.
    Cancer Res; 2003 Jan 15; 63(2):382-5. PubMed ID: 12543791
    [Abstract] [Full Text] [Related]

  • 2. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
    Dings RP, Williams BW, Song CW, Griffioen AW, Mayo KH, Griffin RJ.
    Int J Cancer; 2005 Jun 10; 115(2):312-9. PubMed ID: 15688384
    [Abstract] [Full Text] [Related]

  • 3. Therapeutic targeting of the endothelin a receptor in human ovarian carcinoma.
    Rosanò L, Spinella F, Salani D, Di Castro V, Venuti A, Nicotra MR, Natali PG, Bagnato A.
    Cancer Res; 2003 May 15; 63(10):2447-53. PubMed ID: 12750265
    [Abstract] [Full Text] [Related]

  • 4. Anti-angiogenesis and anti-tumor activity of recombinant anginex.
    Brandwijk RJ, Dings RP, van der Linden E, Mayo KH, Thijssen VL, Griffioen AW.
    Biochem Biophys Res Commun; 2006 Oct 27; 349(3):1073-8. PubMed ID: 16970922
    [Abstract] [Full Text] [Related]

  • 5. Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
    Bello L, Carrabba G, Giussani C, Lucini V, Cerutti F, Scaglione F, Landré J, Pluderi M, Tomei G, Villani R, Carroll RS, Black PM, Bikfalvi A.
    Cancer Res; 2001 Oct 15; 61(20):7501-6. PubMed ID: 11606386
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combination angiostatin and endostatin gene transfer induces synergistic antiangiogenic activity in vitro and antitumor efficacy in leukemia and solid tumors in mice.
    Scappaticci FA, Smith R, Pathak A, Schloss D, Lum B, Cao Y, Johnson F, Engleman EG, Nolan GP.
    Mol Ther; 2001 Feb 15; 3(2):186-96. PubMed ID: 11237675
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.
    van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW.
    FASEB J; 2002 Dec 15; 16(14):1991-3. PubMed ID: 12397082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
    Hu-Lowe DD, Zou HY, Grazzini ML, Hallin ME, Wickman GR, Amundson K, Chen JH, Rewolinski DA, Yamazaki S, Wu EY, McTigue MA, Murray BW, Kania RS, O'Connor P, Shalinsky DR, Bender SL.
    Clin Cancer Res; 2008 Nov 15; 14(22):7272-83. PubMed ID: 19010843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
    Yokoyama Y, Dhanabal M, Griffioen AW, Sukhatme VP, Ramakrishnan S.
    Cancer Res; 2000 Apr 15; 60(8):2190-6. PubMed ID: 10786683
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of cervix carcinoma cells in vivo by endothelin A receptor blockade.
    Bagnato A, Cirilli A, Salani D, Simeone P, Muller A, Nicotra MR, Natali PG, Venuti A.
    Cancer Res; 2002 Nov 15; 62(22):6381-4. PubMed ID: 12438219
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.
    Ma K, Wang C, Geng Q, Fan Y, Ning J, Yang H, Dong X, Dong D, Guo Y, Wei X, Li E, Wu Y.
    Oncol Rep; 2016 Jun 15; 35(6):3505-13. PubMed ID: 27035232
    [Abstract] [Full Text] [Related]

  • 19. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
    Ishikawa H, Nakao K, Matsumoto K, Ichikawa T, Hamasaki K, Nakata K, Eguchi K.
    Hepatology; 2003 Mar 15; 37(3):696-704. PubMed ID: 12601367
    [Abstract] [Full Text] [Related]

  • 20. Potentiation of antitumor activities of carboplatin and camptothecin by interleukin-1 alpha against human ovarian carcinoma in vivo.
    Wang Z, Benchekroun MN, Sinha BK.
    Anticancer Res; 1994 Mar 15; 14(5A):1723-6. PubMed ID: 7847805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.